01289    a2200253   450000500170000002000150001702000180003205000200005024500680007026400420013830000340018033600260021433700280024033800270026850400510029550504790034650500050082565000190083065000340084965000290088365000140091270000310092685600780095720260526123058.0  a1590338936  a978159033893300aRC571bFOC 200300aFocus on Down's syndrome research /cJeffrey A. Malard, editor.  aNew YorkbNova Biomedical Booksc2003  axii, 241 pagesbillustrations  atextbtxt2rdacontent  aunmediatedbn2rdamedia  avolumebnc2rdacarrier  aIncludes bibliographical references and index.0 aDown's syndrome screening with nuchal translucency at 120-140 weeks and maternal serum markers at 149-170 weeks: a prospective study / P. Rozenberg, L. Malagrida, Y. Giudicelli and Y. Ville, H. Cuckle -- Use of fetal cells and fetal DNA recovered from maternal blood for non-invasive prenatal diagnosis / I. Hromadnikova et al. -- Autoimmune thyroid disease and Down syndrome in offspring. Immunogenetic aspects of the infants with Down syndrome / S. Shalitin, M. Phillip --0 a 0aDown syndrome.12aDown Syndromexcomplications.22aDown Syndromexgenetics.22aResearch.1 aMalard, Jeffrey A.eEditor413Table of contentsuhttp://www.loc.gov/catdir/toc/ecip0410/2003024229.html